About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« FDA Approves Biogen Biosimilar for Genentech's Actemra® | Main | Biden Administration Signs Executive Order on Artificial Intelligence »

October 24, 2023

Comments

With respect, and with appreciation for the effort and time that goes into compiling and posting these updates, I would like to gently suggest that the second item—regarding applicant's suggested publication figure—is slightly inaccurate. The posting makes it seem as though the USPTO has announced a change in policy as to whether it will honor applicant's suggested publication figure in an ADS. However, as I read it at least, the actual OG notice is a little different. The OG notice does not seem to indicate any change in honoring (or not) applicant's suggested publication figure in an ADS. Instead, the main thrust of the OG notice is that: "The USPTO is eliminating its ... consideration of the application transmittal letter for the applicant's figure suggestion." This is what I understand is meant by the OG notice's statement that the USPTO will "exclusively use" a suggested publication figure in an ADS.

-kd

AIPLA has asked the USPTO to delay the full transition to PatentCenter due to problems noted by its members: https://www.aipla.org/detail/news/2023/10/30/aipla-comments-on-patent-center-and-the-retirement-of-efs-web-and-private-pair
Carl Oppedahl has noted a number of problems and has a list of “trouble tickets” at https://patentcenter-tickets.oppedahl.com/

The comments to this entry are closed.

February 2024

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29